Maplight Therapeutics Inc (MPLT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | |
| Operating Expenses | 169,083 | 82,946 |
| Operating Income | -169,083 | -82,946 |
| Other Income | 7,931 | 5,366 |
| Pre-tax Income | -161,152 | -77,580 |
| Net Income Continuous | -161,152 | -77,580 |
| Net Income | $-161,152 | $-77,580 |
| EPS Basic Total Ops | -18.56 | -105.38 |
| EPS Basic Continuous Ops | -18.56 | -105.38 |
| EPS Diluted Total Ops | -18.56 | -105.38 |
| EPS Diluted Continuous Ops | -18.56 | -105.38 |
| EPS Diluted Before Non-Recurring Items | N/A | -6.27 |
| EBITDA(a) | $-170,607 | $-83,986 |